CA
NZ
UK
AU
IND
US
Kailera Therapeutics (NASDAQ:KLRA) shares rebounded sharply, closing up more than 16% after touching a fresh 52-week low area near $10 earlier this week. Kailera Therapeutics is an advanced clinical-stage biopharmaceutical company developing a diversified pipeline of injectable and oral GLP-1-based therapies for obesity, with …
Mirum Pharmaceuticals (NASDAQ:MIRM) shares closed sharply higher as investors weighed a string of positive catalysts for the rare disease drugmaker. Mirum Pharmaceuticals is a commercial-stage biopharmaceutical company based in Foster City, California, dedicated to developing and delivering therapies for rare liver and rare genetic …
Moderna (NASDAQ:MRNA) shares surged after the company's entry into the Nasdaq-100 index, replacing Warner Bros. Discovery, took effect before today's market open. Moderna is a biotechnology company that pioneers messenger RNA technology to develop vaccines and therapeutics across infectious disease, oncology, rare disease, and …
Novavax (NASDAQ:NVAX) shares surged on unusually heavy tradingVolumeas investors refocused on the company's partnership-driven turnaround story. Novavax is a biotechnology company that discovers, develops, and commercializes vaccines against serious infectious diseases, best known for its protein-based COVID-19Vaccineand its proprietary Matrix-M adjuvant technology platform.
Teladoc Health (NYSE:TDOC) shares closed higher, rising about 4% in a broad healthcare rebound, bouncing from recent weakness as investors weighed the company's newly launched AI tools for its Solo hospital platform. Teladoc Health is a U.S.-based virtual healthcare company that delivers telehealth services …
UnitedHealth Group (NYSE:UNH) shares closed higher and outperformed a broadly firmer healthcare sector as investors positioned ahead of the company's third-quarter earnings report, scheduled for October 13. UnitedHealth Group is the largest U.S. healthcare company by revenue, operating through its UnitedHealthcare insuranceBusinessand its Optum …
Vaxcyte (NASDAQ:PCVX) shares closed sharply higher as investors continued to digest positive Phase 3 OPUS-1 results for the company's 31-valent pneumococcal conjugate vaccine candidate. Vaxcyte is a clinical-stage vaccine innovation company dedicated to engineering high-fidelity, broad-spectrum conjugate and novel protein vaccines to prevent or …
No company-specific catalyst was confirmed in the filings reviewed, and the stock fell 3.25% on volume about 20 times average. The 52-week range of USD 0.58 to USD 209.50 means the high is about 333 times the current price, which suggests reverse splits, and …
Alumis (NASDAQ:ALMS) shares rose in today's session after the company presented new data from its Phase 3 ONWARD clinical program for envudeucitinib, an oral pill being developed for moderate to severe plaque psoriasis. The results were presented at the Fall Clinical Dermatology Conference 2026.
Arcutis Biotherapeutics (NASDAQ:ARQT) shares rose sharply in today's session after the company presented new data on Zoryve, its roflumilast cream, at the EADV Congress and the Fall Clinical Dermatology Conference 2026. A Phase 2 trial of Zoryve 0.05% cream in infants aged three to …
Please wait processing your request...